 
| IPAD-DB ID | S00117 | 
| Name | 16-Deoxo-paraherquamide | 
| Category | Synthetic compounds | 
| 2D Structure |  | 
| 3D Structure | |
| Molecular Formula | C 2 8 H 3 5 N 3 O 4 | 
| Molecular Weight | 477.6g/mol | 
| IUPAC Name | (1'S, 5'R, 7'S, 8R, 9'S)-4, 4, 5', 10', 10', 13'-hexamethylspiro[10H-[1, 4]dioxepino[2, 3-g]indole-8, 11'-3, 13-diazatetracyclo[5.5.2.01, 9.03, 7]tetradecane]-9, 14'-dione | 
| InChI | InChI=1S/C28H35N3O4/c1-16-11-26-12-19-25(4, 5)28(14-27(19, 15-31(26)13-16)30(6)23(26)33)17-7-8-18-21(20(17)29-22(28)32)34-10-9-24(2, 3)35-18/h7-10, 16, 19H, 11-15H2, 1-6H3, (H, 29, 32)/t16-, 19+, 26+, 27-, 28-/m1/s1 | 
| InChIKey | UCHMXMCBFDOYNC-HTEKFMMOSA-N | 
| Canonical SMILES | CC1CC23CC4C(C5(CC4(CN2C1)N(C3=O)C)C6=C(C7=C(C=C6)OC(C=CO7)(C)C)NC5=O)(C)C | 
| PubChem CID | 127037732 | 
| DrugBank Accession Number | - | 
| CAS Registry Number | - | 
| Molecular Weight(Computed by SwissADME) | 477.6 | 
| Hac(Computed by SwissADME) | 35 | 
| Volume(Computed by ADMETlab 2.0) | 485.281 | 
| Density(Computed by ADMETlab 2.0) | 0.983 | 
| nRing(Computed by ADMETlab 2.0) | 8 | 
| MaxRing(Computed by ADMETlab 2.0) | 14 | 
| nHet(Computed by ADMETlab 2.0) | 7 | 
| fChar(Computed by ADMETlab 2.0) | 0 | 
| nRig(Computed by ADMETlab 2.0) | 35 | 
| Flexibility(Computed by ADMETlab 2.0) | 0 | 
| Stero Centers(Computed by ADMETlab 2.0) | 6 | 
| LogS(Computed by ADMETlab 2.0) | -5.093 | 
| LogD(Computed by ADMETlab 2.0) | 3.251 | 
| logP(Computed by ADMETlab 2.0) | 4.488 | 
| TPSA(Computed by SwissADME) | 71.11 | 
| Hbond Acceptor(Computed by SwissADME) | 5 | 
| Hbond Donor(Computed by SwissADME) | 1 | 
| Rotatable Bonds(Computed by SwissADME) | 0 | 
| GI Absorption(Computed by SwissADME) | High | 
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes | 
| P-gp Substrate(Computed by SwissADME) | No | 
| CYP1A2 Inhibitor(Computed by SwissADME) | No | 
| CYP2C19 Inhibitor(Computed by SwissADME) | No | 
| CYP2C9 Inhibitor(Computed by SwissADME) | No | 
| CYP2D6 Inhibitor(Computed by SwissADME) | No | 
| CYP3A4 Inhibitor(Computed by SwissADME) | No | 
| log Kp(Skin Permeation)(Computed by SwissADME) | -7.17 | 
| Lipinski(Computed by SwissADME) | 0 | 
| Ghose(Computed by SwissADME) | 1 | 
| Veber(Computed by SwissADME) | 0 | 
| Egan(Computed by SwissADME) | 0 | 
| Muegge(Computed by SwissADME) | 0 | 
| Bioavailability Score(Computed by SwissADME) | 0.55 |